BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Biofil Chemicals & Pharmaceuticals Ltd Industry :  Trading
BSE Code
524396
ISIN Demat
INE829A01014
Book Value (Rs)
13.2513829
NSE Symbol
BIOFILCHEM
Divident Yield %
0
Market Cap
(Rs In Cr.)
57
P/E (TTM)
20.53
EPS (TTM)
1.71
Face Value
(Rs)
10
Back
Biofil Chemicals & Pharmaceuticals standalone net profit rises 5.00% in the March 2026 quarter
01-Jun-26   Hrs IST

Net profit of Biofil Chemicals & Pharmaceuticals rose 5.00% to Rs 0.21 crore in the quarter ended March 2026 as against Rs 0.20 crore during the previous quarter ended March 2025. Sales declined 9.34% to Rs 7.57 crore in the quarter ended March 2026 as against Rs 8.35 crore during the previous quarter ended March 2025.

For the full year,net profit rose 398.21% to Rs 2.79 crore in the year ended March 2026 as against Rs 0.56 crore during the previous year ended March 2025. Sales declined 14.97% to Rs 28.40 crore in the year ended March 2026 as against Rs 33.40 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales7.578.35 -9 28.4033.40 -15
OPM %5.681.32 -2.322.54 -
PBDT0.540.34 59 3.731.12 233
PBT0.470.26 81 3.460.74 368
NP0.210.20 5 2.790.56 398

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)